Investing in Innovation
For African healthcare innovators
Investing in Innovation (I3) is a pan-African commercialization support program that aims to help scale African health tech businesses that bring high quality health products (medicines, consumables, medical devices, assistive technologies, etc.) closer to where patients are, at affordable
prices.
Inspired by the progress and promise of African innovators in supply chain, the Bill & Melinda Gates Foundation, alongside Merck Sharp & Dohme (MSD), Afreximbank, AUDA-NEPAD and AmerisourceBergen, are launching I3.
Overview
| Website | Visit website |
| Targets | Africa |
| Sectors | Healthcare |
Team
Programs
- Past Program
Investing in Innovation (i3) – 2023
We are driving scale in data-driven innovation for health product distribution in Africa
- Past Program
Investing in Innovation (i3)
Driving scale in data-driven innovation for health product distribution